Skip to Content

M ET 23 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg)

Pill with imprint M ET 23 is Green, Capsule-shape and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg. It is supplied by Mylan Pharmaceuticals Inc..

Emtricitabine/tenofovir is used in the treatment of pre-exposure prophylaxis; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M ET 23

Emtricitabine and tenofovir disoproxil fumarate 200 mg / 300 mg M ET 23

Emtricitabine and Tenofovir Disoproxil Fumarate

Imprint
M ET 23
Strength
200 mg / 300 mg
Color
Green
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-1930

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.